Monkeypox Concept(BK4583),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BK4583 Monkeypox Concept

Not Yet Opened 11-04 16:00:00 EST

2,428.67

+90.70

+3.88%

High2,437.79	Low2,338.11	Vol54.71M
Open2,338.11	D1 Closing2,337.97	Amplitude4.26%
Mkt Cap0.00	Tradable Cap0.00	Total Shares0.00
T/O2.14B	T/O Rate--	Tradable Shares0.00
P/B2.044085	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BK4583","market":"US","secType":"PLATE","nameCN":"Monkeypox Concept","latestPrice":2428.6687,"timestamp":1793825999999,"preClose":2337.968,"halted":0,"volume":54709524,"delay":0,"changeRate":0.038795,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":90.700684,"latestTime":"11-04 16:00:00 EST","open":2338.1145,"high":2437.7886,"low":2338.1145,"amount":2135329619.103821,"amplitude":0.042633,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1793889000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":2.044085,"peRate":216.938454,"turnoverRate":0.020247,"increases":6,"decrements":4,"flats":0,"marketCap":267572774385.375,"floatMarketCap":266614372259.625},"requestUrl":"/m/hq/s/BK4583/wiki","defaultTab":"wiki","newsList":[{"id":"2681005099","title":"Emergent BioSolutions Gets Anthrax Vaccine Contract Modification up to $22.3m","url":"https://stock-news.laohu8.com/highlight/detail?id=2681005099","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681005099?lang=en_us&edition=fundamental","pubTime":"2026-11-05 06:44","pubTimestamp":1793832240,"startTime":"0","endTime":"0","summary":"Emergent BioSolutions received a contract modification valued at up to $22.3 million to supply its BioThrax vaccine to the Defense Department.The company said the modification, which exercises an option period under its existing contract with the Pentagon, includes an initial delivery valued around $7.4 million set to take place this year. Remaining deliveries are expected to occur next year.\"We're pleased to continue supporting the Department of War's efforts to maintain preparedness against critical biological threats like anthrax,\" the company's head of products business, global government and public affairs, Paul Williams, said Wednesday. \"Delivering dependable access to BioThrax helps protect our nation's service members who have an elevated risk of anthrax exposure.\"","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","EBS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681998600","title":"Emergent BioSolutions receives $22.3M delivery order modification","url":"https://stock-news.laohu8.com/highlight/detail?id=2681998600","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681998600?lang=en_us&edition=fundamental","pubTime":"2026-11-05 06:21","pubTimestamp":1793830877,"startTime":"0","endTime":"0","summary":"Emergent BioSolutions (EBS) announced that it has received a modification exercising an option period under its existing delivery order valued at u...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/emergent-biosolutions-receives-22-3m-delivery-order-modification-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/emergent-biosolutions-receives-22-3m-delivery-order-modification-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4583","EBS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681909515","title":"Arcus Biosciences Q3 Revenue Drops on Lower Gilead Collaboration","url":"https://stock-news.laohu8.com/highlight/detail?id=2681909515","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681909515?lang=en_us&edition=fundamental","pubTime":"2026-11-05 05:53","pubTimestamp":1793829203,"startTime":"0","endTime":"0","summary":"Arcus Biosciences Q3 revenue drops on lower Gilead collaborationOverviewUS biopharma company's Q3 revenue fell sharply yr/yr, mainly due to lower Gilead collaboration revenueQ3 net loss narrowed from ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261104:nL2N46L1EL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BSNM7G36.USD","BK4578","SG9999015945.SGD","IBBQ","LU1061106388.HKD","LU0289739699.SGD","LU1934455194.USD","LU0154245756.USD","BK4532","BK4585","IE00BKVL7J92.USD","BIB","LU1674673691.USD","RCUS","LU0859254822.USD","IE00BZ1G4Q59.USD","TBXU","LU1236620750.USD","IBB","LU0058720904.USD","AMGN","IE00B19Z3581.USD","LU2242652126.USD","LU0861579265.USD","LU1674673428.USD","TMED","LU2087621335.USD","LU0965509010.AUD","LU0965508806.USD","NBIX","PBE","LU0320765992.SGD","SG9999015986.USD","BK4568","LU1057294990.SGD","BK4583","IE00B19Z3B42.SGD","BMED","LU0122379950.USD","LU0965509101.SGD","LU1037948541.HKD","IE00B4R5TH58.HKD","LU2324357040.USD","GILD","MEDI","SG9999015978.USD","PJP","LU1934455863.HKD","LU1023059063.AUD","BBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681492093","title":"Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2681492093","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681492093?lang=en_us&edition=fundamental","pubTime":"2026-11-05 05:35","pubTimestamp":1793828100,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  rallied 4.19% to $174.48 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 1.58% to 7,688.62 and the Dow Jones Industrial Average  rising 3.03% to 53,356.12.The stock's rise snapped a two-day losing streak.Gilead Sciences Inc. closed 0.67% short of its 52-week high of $175.65, which the company reached on October 30th.The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Johnson & Johnson  rose 3.81% to $276.32, Pfizer Inc.  rose 2.63% to $30.79, and Abbott Laboratories  rose 5.59% to $115.51.Trading volume  eclipsed its 50-day average volume of 6.0 M.Data source: Dow Jones Market Data, FactSet. Data compiled November 4, 2026.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1674673691.USD","LU1934455863.HKD","LU1057294990.SGD","LU1066051498.USD","BK4139","SG9999015986.USD","TBXU","LU0320765992.SGD","LU0109394709.USD","LU0289739699.SGD","BK4532","LU0965508806.USD","LU0122379950.USD","BK4568","LU0965509101.SGD","LU1571399168.USD","LU0965509010.AUD","LU1778281490.HKD","LU0823416689.USD","LU2357627491.SGD","GILD","LU2468319806.SGD","IE00B19Z3581.USD","TMED","BK4550","LU0861579265.USD","IE00BSNM7G36.USD","SG9999015978.USD","BK4566","IE00B19Z3B42.SGD","LU1066053197.SGD","LU1839511570.USD","LU1037948541.HKD","IE0002270589.USD","IE00BZ1G4Q59.USD","LU0965509283.SGD","LU0859254822.USD","IBB","BK4585","LU1236620834.HKD","LU1934455277.USD","IE00B3T34201.USD","LU2087621335.USD","LU1061106388.HKD","BK4583","BK4588","SG9999015952.SGD","LU2089984988.USD","LU1430594728.SGD","SG9999015945.SGD","BK4578","LU1236620750.USD","BBH","BIB","IE00BKVL7J92.USD","LU1023059063.AUD","LU2112291526.USD","LU0114720955.EUR","MEDI","LU0234570918.USD","LU1037948897.HKD","LU1674673428.USD","LU0058720904.USD","BMED","IE00B7SZLL34.SGD","LU0882574055.USD","LU1585245621.USD","LU1934455194.USD","IBBQ","LU2324357040.USD","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681093244","title":"Moderna Inc. Stock Rallies 13.1%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2681093244","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681093244?lang=en_us&edition=fundamental","pubTime":"2026-11-05 05:34","pubTimestamp":1793828040,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. climbed 13.1% to $258.38 on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 1.4% to 25,736.51 and the Dow Jones Industrial Average rising 3.0% to 53,356.12.This was the stock's second consecutive day of gains.Moderna Inc. hit a new 52-week high, surpassing its previous peak of $254.48, which the company achieved on October 21st.The stock outperformed some of its peers, as Johnson & Johnson rose 3.8% to $276.32, Pfizer Inc. rose 2.6% to $30.79, and Gilead Sciences Inc. rose 4.19% to $174.48.Trading volume totaled 14.7 million, compared to the 50-day average of 17.9 million.Data source: Dow Jones Market Data, FactSet","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1934455194.USD","LU1066053197.SGD","MEDI","TBXU","WDNA","BBH","LU1585245621.USD","LU1839511570.USD","GNOM","LU1023059063.AUD","IBB","SG9999015945.SGD","BK4533","GILD","MRNX","LU1037948541.HKD","LU0965509283.SGD","IE00BSNM7G36.USD","SG9999015986.USD","LU0122379950.USD","IDNA","LU0234570918.USD","LU0320765992.SGD","MRNA","BIB","BK4578","TMED","LU1674673428.USD","IE00B3T34201.USD","LGHT","LU1061106388.HKD","LU2468319806.SGD","LU1037948897.HKD","LU1934455863.HKD","LU2324357040.USD","LU2112291526.USD","IE0002270589.USD","LU1236620834.HKD","SG9999015978.USD","LU0859254822.USD","LU0889565916.HKD","IBBQ","IE00B19Z3581.USD","LU1571399168.USD","BMED","BK4583","LU2357627491.SGD","BK4551","MRNY","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681553067","title":"Emergent BioSolutions Receives $22.3 Million Delivery Order Modification to Supply Biothrax® (Anthrax Vaccine Adsorbed) to the U.S. Department of War","url":"https://stock-news.laohu8.com/highlight/detail?id=2681553067","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681553067?lang=en_us&edition=fundamental","pubTime":"2026-11-05 05:05","pubTimestamp":1793826355,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261104:nFWN46L2Y7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4583","BK4139","EBS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681506762","title":"Emergent BioSolutions - First Delivery Valued at $7.40 Mln to Begin This Year; Remaining Deliveries Expected in 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2681506762","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681506762?lang=en_us&edition=fundamental","pubTime":"2026-11-05 05:05","pubTimestamp":1793826355,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261104:nFWN46L2Y7:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4583","EBS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680105747","title":"Gilead and Kite Present Blood Cancer Therapy Data at ASH Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2680105747","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680105747?lang=en_us&edition=fundamental","pubTime":"2026-11-04 22:19","pubTimestamp":1793801985,"startTime":"0","endTime":"0","summary":"Gilead and Kite Present Blood Cancer Therapy Data at ASH Annual MeetingGilead Sciences and Kite will attend the 68th American Society of Hematology Annual Meeting and Exposition on December 12-15, 202","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261104:nNDL15vCqR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBB","IE00BZ1G4Q59.USD","LU1037948541.HKD","LU2324357040.USD","LU0965508806.USD","LU0122379950.USD","LU2468319806.SGD","BK4588","BK4578","BBH","LU1571399168.USD","BMED","LU1778281490.HKD","LU1934455277.USD","LU0320765992.SGD","BK4583","LU0859254822.USD","MEDI","SG9999015945.SGD","TMED","IE00BSNM7G36.USD","IBBQ","LU1236620750.USD","LU0234570918.USD","LU0965509283.SGD","LU2087621335.USD","BIB","GILD","BK4532","LU1585245621.USD","LU0882574055.USD","TBXU","LU1674673428.USD","LU1037948897.HKD","IE00BKVL7J92.USD","LU1057294990.SGD","BK4566","LU1061106388.HKD","LU0109394709.USD","LU0823416689.USD","BK4550","LU2112291526.USD","BK4139","LU0965509101.SGD","SG9999015952.SGD","LU1236620834.HKD","IE0002270589.USD","LU0861579265.USD","LU0114720955.EUR","IE00B19Z3581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680057472","title":"Gilead to Present 18-Month Anito-Cel Trial Follow-up Data in Multiple Myeloma at ASH 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2680057472","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680057472?lang=en_us&edition=fundamental","pubTime":"2026-11-04 22:19","pubTimestamp":1793801951,"startTime":"0","endTime":"0","summary":"Gilead to Present 18-Month Anito-cel Trial Follow-Up Data in Multiple Myeloma at ASH 2026Gilead Sciences and Kite will present 23 abstracts, including seven oral presentations, at ASH on December 12-1","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261104:nNDL7pmdGs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDI","LU1061106388.HKD","LU1674673428.USD","TMED","LU1037948541.HKD","BK4585","SG9999015978.USD","BK4550","LU2112291526.USD","LU2357627491.SGD","LU0965508806.USD","LU0114720955.EUR","LU1934455194.USD","SG9999015952.SGD","LU0109394709.USD","BBH","SG9999015945.SGD","LU1057294990.SGD","LU1023059063.AUD","LU0965509101.SGD","IE00B7SZLL34.SGD","LU0859254822.USD","IE00BKVL7J92.USD","LU1934455277.USD","LU0320765992.SGD","LU2468319806.SGD","GILD","IBBQ","LU0889565916.HKD","LU1066051498.USD","LU1236620750.USD","LU0965509010.AUD","LU1037948897.HKD","LU2324357040.USD","LU2089984988.USD","IE00B19Z3581.USD","IBB","BK4583","LU0965509283.SGD","TBXU","BIB","LU0882574055.USD","LU2087621335.USD","LU0861579265.USD","LU1236620834.HKD","LU1571399168.USD","BMED","LU0234570918.USD","IE0002270589.USD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680169057","title":"Gilead and Kite Advance Leadership with New Data Across Pipeline and Portfolio at Ash 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2680169057","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680169057?lang=en_us&edition=fundamental","pubTime":"2026-11-04 22:15","pubTimestamp":1793801700,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261104:nTUA5YRSNY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1236620750.USD","LU1934455277.USD","MEDI","LU0882574055.USD","IE00B7SZLL34.SGD","IE00BZ1G4Q59.USD","SG9999015952.SGD","LU1571399168.USD","TBXU","IBBQ","LU1778281490.HKD","IE00BSNM7G36.USD","BK4583","LU2087621335.USD","BK4585","LU0320765992.SGD","LU0289739699.SGD","LU0861579265.USD","LU1037948541.HKD","IE00B19Z3581.USD","BK4532","BIB","LU0859254822.USD","LU1236620834.HKD","LU1430594728.SGD","SG9999015978.USD","BK4568","LU2468319806.SGD","LU0965509101.SGD","TMED","BBH","IBB","LU0823416689.USD","LU1839511570.USD","LU0234570918.USD","LU2324357040.USD","IE00BKVL7J92.USD","GILD","LU1037948897.HKD","LU1585245621.USD","LU0122379950.USD","BMED","SG9999015945.SGD","BK4550","LU2089984988.USD","LU1057294990.SGD","BK4588","LU0965509010.AUD","BK4566","IE00B19Z3B42.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680055764","title":"Tonix Pharmaceuticals Presents at Guggenheim's Healthcare Innovation Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2680055764","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680055764?lang=en_us&edition=fundamental","pubTime":"2026-11-04 20:12","pubTimestamp":1793794350,"startTime":"0","endTime":"0","summary":"Tonix Pharmaceuticals Presents at Guggenheim's Healthcare Innovation ConferenceTonix Pharmaceuticals will attend Guggenheim’s 3rd Annual Healthcare Innovation Conference in Boston on Nov. 10, 2026.CEO","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261104:nNDL4lRgqT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2W23.USD","IE00BKPKM429.USD","IE00BN0W2T93.GBP","IE00BGHQF748.EUR","LU2095319765.USD","IE00BQXX3C00.GBP","LU0314104364.USD","SG9999014039.USD","BK4588","BK4112","IE00BN0W2V16.EUR","NDAQ","IE00BQXX3D17.EUR","LU2210149790.SGD","BCDF","IE00B3QW5Z07.USD","SG9999014005.SGD","SG9999014021.USD","LU2210150020.SGD","BK4583","IE00BQXX3F31.USD","TNXP","IE00B64PRP62.GBP","BK4139","BK4585","SG9999014013.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680205315","title":"Viatris Declares Quarterly Dividend of $0.12 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2680205315","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680205315?lang=en_us&edition=fundamental","pubTime":"2026-11-04 19:59","pubTimestamp":1793793587,"startTime":"0","endTime":"0","summary":"Viatris Declares Quarterly Dividend of $0.12 Per ShareViatris declared a quarterly dividend of $0.12 per common share on November 2, 2026.The dividend is payable December 16, 2026, to shareholders of ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261104:nNDL8Dtgfm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2087621335.USD","BK4588","VTRS","BK4007","BK4583","LU1839511570.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680053357","title":"Inovio Pharmaceuticals Inc. Stock Underperforms Tuesday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2680053357","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680053357?lang=en_us&edition=fundamental","pubTime":"2026-11-04 06:24","pubTimestamp":1793744640,"startTime":"0","endTime":"0","summary":"DJ Inovio Pharmaceuticals Inc. Stock Underperforms Tuesday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Inovio Pharmaceuticals Inc.  plunged 12.17% to $1.66 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index  rising 0.83% to 25,372.01 and the Dow Jones Industrial Average  falling 0.38% to 51,786.72.Inovio Pharmaceuticals Inc. closed 38.97% short of its 52-week high of $2.72, which the company achieved on December 17th.The stock underperformed when compared to some of its competitors Tuesday, as Johnson & Johnson  fell 1.62% to $266.17, Statera Biopharma Inc.  remained unchanged, and Pfizer Inc.  fell 2.18% to $30.00.Trading volume  eclipsed its 50-day average volume of 9.5 M.Data source: Dow Jones Market Data, FactSet. Data compiled November 3, 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4139","INO","BK4583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680703562","title":"Quest Diagnostics Inc. Stock Underperforms Tuesday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2680703562","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680703562?lang=en_us&edition=fundamental","pubTime":"2026-11-04 06:00","pubTimestamp":1793743200,"startTime":"0","endTime":"0","summary":"DJ Quest Diagnostics Inc. Stock Underperforms Tuesday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Quest Diagnostics Inc.  slid 1.50% to $247.06 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index  rising 0.36% to 7,568.92 and the Dow Jones Industrial Average  falling 0.38% to 51,786.72.This was the stock's third consecutive day of losses.Quest Diagnostics Inc. closed 3.86% short of its 52-week high of $256.99, which the company achieved on October 30th.The stock underperformed when compared to some of its competitors Tuesday, as UnitedHealth Group Inc.  rose 1.00% to $404.44, IQVIA Holdings Inc.  rose 1.61% to $262.59, and Centene Corp.  rose 1.43% to $67.48.Trading volume  eclipsed its 50-day average volume of 1.1 M.Data source: Dow Jones Market Data, FactSet. Data compiled November 3, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0950375773.USD","BK4196","BK4583","LU2506951875.HKD","DGX","BK4585","BK4588","LU0823417737.USD","LU2506951958.HKD","LU1854103824.USD","BK4567","LU2506952097.USD","LU1854104046.USD","LU2506952170.USD","LU0823417653.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680088137","title":"Gilead Sciences Inc. Stock Underperforms Tuesday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2680088137","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680088137?lang=en_us&edition=fundamental","pubTime":"2026-11-04 05:34","pubTimestamp":1793741640,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Underperforms Tuesday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  slipped 1.68% to $167.47 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index  rising 0.36% to 7,568.92 and the Dow Jones Industrial Average  falling 0.38% to 51,786.72.This was the stock's second consecutive day of losses.Gilead Sciences Inc. closed 4.66% short of its 52-week high of $175.65, which the company achieved on October 30th.The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson  fell 1.62% to $266.17, Pfizer Inc.  fell 2.18% to $30.00, and Abbott Laboratories  fell 0.69% to $109.40.Trading volume  eclipsed its 50-day average volume of 6.0 M.Data source: Dow Jones Market Data, FactSet. Data compiled November 3, 2026.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1236620750.USD","LU2087621335.USD","LU1571399168.USD","LU1674673691.USD","BK4550","LU1839511570.USD","MEDI","BK4532","BK4139","IE0002270589.USD","LU0965509283.SGD","LU1023059063.AUD","LU1037948897.HKD","IE00B19Z3581.USD","LU1778281490.HKD","LU0823416689.USD","LU1934455194.USD","LU0965508806.USD","TMED","LU0965509010.AUD","LU1037948541.HKD","LU0320765992.SGD","IBB","BK4588","LU0114720955.EUR","LU2468319806.SGD","BBH","LU0889565916.HKD","BMED","IE00B19Z3B42.SGD","BK4585","LU0861579265.USD","LU1585245621.USD","BIB","LU1066053197.SGD","LU1934455863.HKD","BK4578","SG9999015952.SGD","LU0234570918.USD","IBBQ","IE00B3T34201.USD","IE00BZ1G4Q59.USD","LU1674673428.USD","LU1057294990.SGD","BK4583","IE00B7SZLL34.SGD","LU1066051498.USD","IE00BKVL7J92.USD","IE00BSNM7G36.USD","LU1430594728.SGD","LU1934455277.USD","SG9999015945.SGD","LU0289739699.SGD","LU2324357040.USD","LU0058720904.USD","LU2357627491.SGD","LU0859254822.USD","LU2112291526.USD","LU0965509101.SGD","BK4566","LU2089984988.USD","SG9999015986.USD","GILD","LU0882574055.USD","LU1061106388.HKD","LU0109394709.USD","SG9999015978.USD","BK4568","LU1236620834.HKD","TBXU","LU0122379950.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680508779","title":"Why Gilead Sciences (GILD) Is Back In The Spotlight","url":"https://stock-news.laohu8.com/highlight/detail?id=2680508779","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680508779?lang=en_us&edition=fundamental","pubTime":"2026-11-04 01:22","pubTimestamp":1793726566,"startTime":"0","endTime":"0","summary":"Gilead Sciences (GILD) just turned a strong third quarter into a louder statement. An earnings beat linked to HIV treatments, a higher HIV growth outlook and a fresh record share price have pulled renewed attention to the stock.\nThat reaction sits on top of a powerful run. Gilead Sciences has delivered a 40.07% year to date share price return and a 25.94% 90 day share price gain. The 5 year total shareholder return of 208.52% points to momentum that has been building over several years rather...","market":"sg","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/company-cover/29002-card/1789028982321","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/company-cover/29002-card/1789028982321"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gild/gilead-sciences/news/why-gilead-sciences-gild-is-back-in-the-spotlight","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gild/gilead-sciences/news/why-gilead-sciences-gild-is-back-in-the-spotlight","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2468319806.SGD","BK4588","IE00BSNM7G36.USD","LU1057294990.SGD","LU2087621335.USD","LU0109394709.USD","LU1934455277.USD","IE00B3T34201.USD","BK4139","BBH","LU0289739699.SGD","LU1674673691.USD","BK4583","IE00B19Z3B42.SGD","LU1674673428.USD","LU0114720955.EUR","LU0965509101.SGD","LU0122379950.USD","BK4585","LU2112291526.USD","LU1571399168.USD","BIB","BK4568","IE00B7SZLL34.SGD","LU1037948897.HKD","LU1934455863.HKD","LU1037948541.HKD","GILD","LU1023059063.AUD","LU2324357040.USD","BK4532","LU1236620834.HKD","MEDI","SG9999015978.USD","IBBQ","SG9999015986.USD","LU1934455194.USD","BMED","TMED","LU1066051498.USD","LU0058720904.USD","LU0965508806.USD","LU1430594728.SGD","TBXU","LU0965509010.AUD","LU1839511570.USD","LU1236620750.USD","LU0882574055.USD","LU1061106388.HKD","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680972707","title":"Emergent BioSolutions trading resumes","url":"https://stock-news.laohu8.com/highlight/detail?id=2680972707","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680972707?lang=en_us&edition=fundamental","pubTime":"2026-11-03 22:41","pubTimestamp":1793716868,"startTime":"0","endTime":"0","summary":"09:37 EST Emergent BioSolutions (EBS) trading resumes Published first on TheFly – the ultimate source for real-time, market-moving breaking financi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/emergent-biosolutions-trading-resumes-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/emergent-biosolutions-trading-resumes-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EBS","BK4139","BK4583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680168727","title":"NYSE Halt Add Info Lst $6.455100","url":"https://stock-news.laohu8.com/highlight/detail?id=2680168727","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680168727?lang=en_us&edition=fundamental","pubTime":"2026-11-03 22:32","pubTimestamp":1793716345,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261103:nAQN2MRQ5O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","EBS","BK4583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680972904","title":"Emergent Shares Slide as 3Q Revenue Shrinks","url":"https://stock-news.laohu8.com/highlight/detail?id=2680972904","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680972904?lang=en_us&edition=fundamental","pubTime":"2026-11-03 21:01","pubTimestamp":1793710860,"startTime":"0","endTime":"0","summary":"Shares of Emergent BioSolutions tumbled premarket after the maker of opioid overdose remedies and other emergency medications swung to a third-quarter loss due to a sharp drop in orders from the U.S. government and elsewhere.The company, which also makes antidotes for anthrax and other diseases, logged a loss of $32.7 million, or 64 cents a share, in contrast to a profit of $51.2 million, or 91 cents a share, a year earlier.Stripping out certain one-time items, Emergent posted an adjusted loss of 36 cents a share.Third-quarter revenue plunged 52% to $110 million. Revenue from Naloxone, the products preventing opioid overdoses, slid 42% to $43.5 million, on an adverse mix of sales via public-health outlets in the U.S.Revenue from smallpox products plunged 68% to $26.7 million, reflecting changes in timing of U.S. government orders.Emergent BioSolutions slashed its revenue projection to a range of $600 million to $645 million for the year from a previous $645 million-to-$675 million targ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EBS","BK4139","BK4583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680728789","title":"BioNTech Q3 2026 Swings to Net Profit of €184.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2680728789","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680728789?lang=en_us&edition=fundamental","pubTime":"2026-11-03 19:46","pubTimestamp":1793706387,"startTime":"0","endTime":"0","summary":"BioNTech Q3 2026 swings to net profit of 184.5 millionBioNTech swung to a third-quarter 2026 net profit of 184.5 million from a year-earlier loss of 28.7 million.Revenues fell 15% year over year to 1.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261103:nNDL8hZ8hP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","SG9999014021.USD","BNTX","BBH","IBBQ","LU1430594728.SGD","LU0889565916.HKD","LU1778281490.HKD","SG9999015978.USD","LU1674673691.USD","LU2087621335.USD","LU1066051498.USD","SG9999015952.SGD","IE00BQXX3C00.GBP","LU2324357040.USD","LU0289739699.SGD","IE00BQXX3D17.EUR","IBB","LU0058720904.USD","LU1037948897.HKD","TBXU","BMED","LU1934455277.USD","IE00BN0W2V16.EUR","NDAQ","SG9999014039.USD","IE00BKVL7J92.USD","GILD","BK4583","LU0859254822.USD","IE00BGHQF748.EUR","LU0965509101.SGD","SG9999015945.SGD","TMED","LU0823416689.USD","IE00BSNM7G36.USD","BK4578","BIB","BK4112","BK4548","BCDF","BK4566","LU1023059063.AUD","LU1839511570.USD","LU0114720955.EUR","LU1934455194.USD","LU2112291526.USD","MEDI","BK4588","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":-0.0071},{"period":"1month","weight":-0.0104},{"period":"3month","weight":-0.0023},{"period":"6month","weight":0.0396},{"period":"1year","weight":0.1356},{"period":"ytd","weight":0.1245}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"name":"BK4583","nameEN":"BK4583"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.1","shortVersion":"4.52.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Monkeypox Concept(BK4583),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Monkeypox Concept(BK4583) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Monkeypox Concept,BK4583,Monkeypox Concept股票,Monkeypox Concept股票老虎,Monkeypox Concept股票老虎国际,Monkeypox Concept行情,Monkeypox Concept股票行情,Monkeypox Concept股价,Monkeypox Concept股市,Monkeypox Concept股票价格,Monkeypox Concept股票交易,Monkeypox Concept股票购买,Monkeypox Concept股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Monkeypox Concept(BK4583),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Monkeypox Concept(BK4583) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction